- Report
- April 2026
- 287 Pages
Global
From €2303EUR$2,500USD£1,941GBP
- Report
- January 2026
- 292 Pages
Global
From €2303EUR$2,500USD£1,941GBP
- Report
- May 2026
- 179 Pages
Global
From €4145EUR$4,500USD£3,495GBP
- Report
- May 2026
- 185 Pages
Global
From €4145EUR$4,500USD£3,495GBP
- Report
- March 2026
- 196 Pages
Global
From €4145EUR$4,500USD£3,495GBP
- Report
- September 2026
- 197 Pages
Global
From €3265EUR$3,545USD£2,753GBP
€3628EUR$3,939USD£3,059GBP
- Report
- September 2026
- 183 Pages
Global
From €3265EUR$3,545USD£2,753GBP
€3628EUR$3,939USD£3,059GBP
- Report
- September 2026
- 193 Pages
Global
From €3265EUR$3,545USD£2,753GBP
€3628EUR$3,939USD£3,059GBP
- Report
- September 2026
- 196 Pages
Global
From €3265EUR$3,545USD£2,753GBP
€3628EUR$3,939USD£3,059GBP
- Report
- September 2026
- 191 Pages
Global
From €3265EUR$3,545USD£2,753GBP
€3628EUR$3,939USD£3,059GBP
- Report
- September 2026
- 193 Pages
Global
From €3265EUR$3,545USD£2,753GBP
€3628EUR$3,939USD£3,059GBP
- Report
- October 2026
- 402 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 483 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 482 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- July 2026
- 120 Pages
Global
From €4375EUR$4,750USD£3,689GBP
- Report
- February 2026
- 250 Pages
Global
From €4136EUR$4,490USD£3,487GBP
- Report
- August 2026
- 250 Pages
Global
From €4136EUR$4,490USD£3,487GBP
- Report
- May 2026
- 436 Pages
Global
From €4136EUR$4,490USD£3,487GBP
- Report
- May 2026
- 288 Pages
Global
From €4136EUR$4,490USD£3,487GBP
- Report
- April 2026
- 250 Pages
Global
From €4136EUR$4,490USD£3,487GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more